Skip to main content
Clinical Trials/PACTR202201521544765
PACTR202201521544765CompletedPhase 1

ocal anaesthesia prior to intramuscular Magnesium Sulphate injection to reduce pain: A randomised crossover pilot study

niversity of Botswana0 sites34 target enrollmentStarted: March 13, 2021Last updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
34

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patient with preeclampsia or eclampsia receiving magnesium sulphate
  • Client willing and consenting to take part in the study
  • Conscious, able to give consent and give answers to questions about pain and preference

Exclusion Criteria

  • Age less than 18 years (consenting age )
  • critically ill patient (very sick, unstable or unconscious patient, GCS <13 or haemo-dynamically unstable patient)
  • Allergic to magnesium sulphate or lignocaine

Investigators

Sponsor
niversity of Botswana

Similar Trials

ocal anaesthesia prior to intramuscular... | Clinical Trial